STUDY OBJECTIVE: To compare, in pairwise fashion, the effects of @entity1875 and @entity4671 during ambulatory cardioversion and early recovery. DESIGN: Clinical, prospective, randomized, blinded, monocenter, pairwise, comparative study SETTING: OR and recovery area of the electrophysiological department, University Hospital Ghent, Belgium. @entity1 : 34 @entity1 with @entity943 who were scheduled for repetitive electrical cardioversion, of whom 25 @entity1 completed the study. INTERVENTIONS: Nonpremedicated @entity1 received during the first cardioversion either @entity1875 (1 mg/kg) or @entity4671 (0.2 mg/kg) until @entity909 , followed by electrical external cardioversion. If after restoration of sinus rhythm for at least 1 day, @entity943 reoccurred, a second session was performed a week later, using the other induction drug. MEASUREMENTS: Systolic and diastolic blood pressure values taken before drug administration, at @entity909 , 60 seconds after cardioversion, and awake; the number of shocks, the total amount of energy, the number of @entity1 in which we failed to restore sinus rhythm, the time before opening eyes, answering simple questions and be able to sit, were all noted. Aldrete scores and the Steward postanesthetic recovery scores were noted every minute until 10 minutes after the external cardioversion. Recovery tests were performed and evaluated 5, 10, 15, and 20 minutes after energy delivery. MAIN RESULTS: Number of shocks, amount of energy, and blood pressure values were comparable in both groups. Recovery times and Aldrete and Steward postanesthetic recovery scores showed a faster awakening in @entity1 who were induced with @entity1875 . Overall performance of the psychomotor test was better in the @entity1875 group, and most pronounced at 10 and 15 minutes. CONCLUSIONS: @entity4671 and @entity1875 are both useful during ambulatory external electrical cardioversion. The described doses maintain stable hemodynamic conditions in nonpremedicated @entity1 . Recovery scores and psychomotor test indicate a faster recovery in the @entity1875 group. However, no intergroup differences were noted at 20 minutes after the cardioversion. A safe discharge of all @entity1 from the critical care unit or postanesthesia care unit to the ward can be considered after 30 minutes.

Ambulatory electrical external cardioversion with XXXX or @entity4671 .

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity909 :: ('MESH:D014474', 'Disease') :: ['loss of consciousness'] @entity1875 :: ('MESH:D015742', 'Chemical') :: ['propofol'] @entity4671 :: ('MESH:D005045', 'Chemical') :: ['etomidate', 'Etomidate'] @entity943 :: ('MESH:D001145', 'Disease') :: ['atrial arrhythmia']
@entity1875 :: (MESH:D015742,Chemical) :: ['propofol']
